Astrana Health, Inc. (ASTH)
Astrana Health, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Astrana Health, Inc. (ASTH) is a Medical - Care Facilities company based in US with a market capitalization of $1.9B. Revenue grew 56.4% year-over-year and the company generated $104.5M in free cash flow. This page tracks ASTH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 1.9K employees · IPO Mar 11, 2009
Valuation
Valuation & price
$38.26 · as of May 17, 2026 · -15.0% vs 52w high
84.0
P/E ratio
Latest-FY diluted EPS
2.41
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$1.9B
Market cap
56.4%
Revenue growth (YoY)
9.3%
Gross margin
$104.5M
Free cash flow (USD)
$648.7M
Net debt
2.9%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 8, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventExecutive Retirement and AppointmentJul 1, 2026Filing
- 8-K eventEquity Incentive Plan UpdateJun 10, 2026Filing
- 8-K eventCorporate Presentation UpdateMay 12, 2026Filing
- 8-K eventCMO ResignationMay 12, 2026Filing
- Quarterly report10-Q FiledMay 8, 2026Filing
- 8-K eventEarnings ReleaseMay 7, 2026Filing
Questions
Frequently asked questions
What is Astrana Health, Inc.'s market cap?
Astrana Health, Inc. (ASTH) has a market capitalization of $1.9B.
What is ASTH's P/E ratio?
ASTH trades at a price-to-earnings ratio of 84.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is ASTH's price-to-book (P/B) ratio?
ASTH trades at 2.41 times book value per share.
Are insiders buying ASTH stock?
SEC Form 4 filings show no open-market insider buys at Astrana Health, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Care Facilities
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.